Form 4 holding
Chief Financial Officer
UroGen Pharma Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 37,753
- Estimated value
- $493,809
- Report date
- 09 Sep 2024
- Price
- $13.08
- Ownership
- Direct
Dong Kim - Chief Financial Officer at UroGen Pharma Ltd.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- URGN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Dong Kim since 06 Oct 2025
Reported holdings for Dong Kim in UroGen Pharma Ltd.
Form 4 holding
Chief Financial Officer
UroGen Pharma Ltd.
- Security class
- Stock Option (right to buy)
- Shares / value
- 20,000
- Estimated value
- Report date
- 25 Mar 2022
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Chief Financial Officer
UroGen Pharma Ltd.
- Security class
- Restricted Stock Units
- Shares / value
- 5,000
- Estimated value
- Report date
- 09 Sep 2024
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Dong Kim in UroGen Pharma Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.